A Study of EDG-7500 in Adults With Hypertrophic Cardiomyopathy (CIRRUS-HCM)

Running, not enrolling · Phase 2

Conditions studied: Hypertrophic Cardiomyopathy

In brief

This study is being conducted in order to understand the safety and effects of different doses of EDG-7500 as a single dose in adults with obstructive hypertrophic cardiomyopathy (oHCM) and as multiple doses in adults with obstructive or nonobstructive hypertrophic cardiomyopathy (nHCM).

Key facts

Study ID
NCT06347159
Run by
Edgewise Therapeutics, Inc.
People needed
79
Starts
2024-04-11
Expected to finish
2027-12-01
Last updated by the study team
2026-07-31

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.